Li Li

Role of interleukin-21 and interleukin-21 receptor polymorphisms in the treatment of HBeAg-positive chronic hepatitis B patients with peginterferon

Juan-juan Fu, Xiucheng Pan, Yan Li, 2018, Medicine.

Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma.

Junnian Zheng, Juan-juan Fu, Xiucheng Pan, 2013, Oncology letters.

VDR rs7975232/ApaI genetic variation predicts sustained HBsAg loss in HBeAg‐positive chronic hepatitis B patients treated with pegylated interferon

Jun Wang, J. Li, Juan-juan Fu, 2018, Journal of medical virology.

70 PEGYLATED INTERFERON ALPHA MODULATES INNATE IMMUNITY IN EAG POSITIVE CHRONIC HEPATITIS B AND DETERMINES CHANGES IN HBSAG QUANTIFICATION

I. Ushiro-Lumb, G. Foster, M. Maini, 2011 .

Development and validation of a nomogram to predict recompensation in HBV-related cirrhosis with ascites as the single first decompensating event

Jiaming Shen, Juanjuan Fu, Xiucheng Pan, 2023, Scandinavian journal of gastroenterology.

Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors

Xia Wang, Li Li, Guangde Yang, 2024, Journal of hepatocellular carcinoma.